Insulet Corporation (PODD)
USD 243.6
(-5.14%)
USD 243.6
(-5.14%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.36 Billion USD | -0.57% |
| 2022 | 1.37 Billion USD | 10.05% |
| 2021 | 1.24 Billion USD | 19.65% |
| 2020 | 1.04 Billion USD | 17.55% |
| 2019 | 887.9 Million USD | 49.99% |
| 2018 | 591.97 Million USD | 4.56% |
| 2017 | 566.17 Million USD | 70.14% |
| 2016 | 332.76 Million USD | 93.51% |
| 2015 | 171.96 Million USD | 0.41% |
| 2014 | 171.25 Million USD | 43.86% |
| 2013 | 119.04 Million USD | 14.76% |
| 2012 | 103.73 Million USD | -4.43% |
| 2011 | 108.54 Million USD | 56.32% |
| 2010 | 69.43 Million USD | -28.4% |
| 2009 | 96.97 Million USD | 14.09% |
| 2008 | 85 Million USD | 431.05% |
| 2007 | 16 Million USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 8.3 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.35 Billion USD | -0.2% |
| 2024 Q1 | 1.36 Billion USD | -0.28% |
| 2023 Q4 | 1.36 Billion USD | -0.31% |
| 2023 Q1 | 1.36 Billion USD | -0.4% |
| 2023 Q2 | 1.36 Billion USD | -0.01% |
| 2023 FY | 1.36 Billion USD | -0.57% |
| 2023 Q3 | 1.37 Billion USD | 0.15% |
| 2022 Q4 | 1.37 Billion USD | -0.4% |
| 2022 FY | 1.37 Billion USD | 10.05% |
| 2022 Q3 | 1.37 Billion USD | -0.39% |
| 2022 Q1 | 1.39 Billion USD | 11.35% |
| 2022 Q2 | 1.38 Billion USD | -0.38% |
| 2021 Q4 | 1.24 Billion USD | -0.65% |
| 2021 Q2 | 1.23 Billion USD | 17.46% |
| 2021 Q1 | 1.05 Billion USD | 0.76% |
| 2021 FY | 1.24 Billion USD | 19.65% |
| 2021 Q3 | 1.25 Billion USD | 1.76% |
| 2020 Q1 | 899 Million USD | 1.25% |
| 2020 Q3 | 921.5 Million USD | 1.24% |
| 2020 Q4 | 1.04 Billion USD | 13.26% |
| 2020 Q2 | 910.2 Million USD | 1.25% |
| 2020 FY | 1.04 Billion USD | 17.55% |
| 2019 Q4 | 887.9 Million USD | -9.93% |
| 2019 Q2 | 607.35 Million USD | 1.29% |
| 2019 Q3 | 985.77 Million USD | 62.31% |
| 2019 Q1 | 599.6 Million USD | 1.29% |
| 2019 FY | 887.9 Million USD | 49.99% |
| 2018 FY | 591.97 Million USD | 4.56% |
| 2018 Q4 | 591.97 Million USD | 1.28% |
| 2018 Q1 | 569.87 Million USD | 0.65% |
| 2018 Q2 | 577.11 Million USD | 1.27% |
| 2018 Q3 | 584.48 Million USD | 1.28% |
| 2017 FY | 566.17 Million USD | 70.14% |
| 2017 Q4 | 566.17 Million USD | 64.13% |
| 2017 Q3 | 344.95 Million USD | 1.21% |
| 2017 Q2 | 340.83 Million USD | 1.21% |
| 2017 Q1 | 336.76 Million USD | 1.2% |
| 2016 Q2 | 175.69 Million USD | 1.16% |
| 2016 Q4 | 332.76 Million USD | 1.16% |
| 2016 FY | 332.76 Million USD | 93.51% |
| 2016 Q1 | 173.68 Million USD | 1.0% |
| 2016 Q3 | 328.96 Million USD | 87.24% |
| 2015 Q4 | 171.96 Million USD | -1.69% |
| 2015 Q2 | 174.53 Million USD | -0.01% |
| 2015 FY | 171.96 Million USD | 0.41% |
| 2015 Q3 | 174.93 Million USD | 0.23% |
| 2015 Q1 | 174.56 Million USD | 1.93% |
| 2014 Q4 | 171.25 Million USD | 0.44% |
| 2014 FY | 171.25 Million USD | 43.86% |
| 2014 Q1 | 120.93 Million USD | 1.59% |
| 2014 Q2 | 174.72 Million USD | 44.48% |
| 2014 Q3 | 170.51 Million USD | -2.41% |
| 2013 Q1 | 106.18 Million USD | 2.37% |
| 2013 Q4 | 119.04 Million USD | 1.56% |
| 2013 Q3 | 117.2 Million USD | 4.92% |
| 2013 Q2 | 111.71 Million USD | 5.21% |
| 2013 FY | 119.04 Million USD | 14.76% |
| 2012 FY | 103.73 Million USD | -4.43% |
| 2012 Q1 | 110.84 Million USD | 2.12% |
| 2012 Q4 | 103.73 Million USD | 2.18% |
| 2012 Q3 | 101.51 Million USD | 2.15% |
| 2012 Q2 | 99.38 Million USD | -10.34% |
| 2011 Q4 | 108.54 Million USD | 2.09% |
| 2011 FY | 108.54 Million USD | 56.32% |
| 2011 Q3 | 106.31 Million USD | 2.06% |
| 2011 Q2 | 104.17 Million USD | 47.02% |
| 2011 Q1 | 70.85 Million USD | 2.05% |
| 2010 FY | 69.43 Million USD | -28.4% |
| 2010 Q1 | 98.21 Million USD | 1.28% |
| 2010 Q2 | 92.29 Million USD | -6.03% |
| 2010 Q3 | 94.17 Million USD | 2.04% |
| 2010 Q4 | 69.43 Million USD | -26.28% |
| 2009 Q1 | 81.44 Million USD | -4.18% |
| 2009 Q4 | 96.97 Million USD | 1.12% |
| 2009 Q3 | 95.9 Million USD | 15.43% |
| 2009 Q2 | 83.07 Million USD | 2.01% |
| 2009 FY | 96.97 Million USD | 14.09% |
| 2008 Q4 | 85 Million USD | 0.0% |
| 2008 Q2 | 85 Million USD | 537.28% |
| 2008 FY | 85 Million USD | 431.05% |
| 2008 Q1 | 13.33 Million USD | -16.67% |
| 2008 Q3 | 85 Million USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | 21.34 Million USD | 0.0% |
| 2007 Q3 | 18.67 Million USD | -12.5% |
| 2007 Q4 | 16 Million USD | -14.28% |
| 2007 FY | 16 Million USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q3 | 6.33 Million USD | 0.0% |
| 2006 FY | - USD | -100.0% |
| 2005 FY | 8.3 Million USD | 0.0% |
| 2005 Q4 | 8.3 Million USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | -3684.832% |
| BrainsWay Ltd. | 239 Thousand USD | -571615.481% |
| Cerus Corporation | 59.79 Million USD | -2185.103% |
| Envoy Medical, Inc. | 404 Thousand USD | -338117.822% |
| electroCore, Inc. | 537 Thousand USD | -254350.652% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -11386566.667% |
| IceCure Medical Ltd | 376 Thousand USD | -363304.255% |
| Inogen, Inc. | 18.27 Million USD | -7378.927% |
| OrthoPediatrics Corp. | 13.45 Million USD | -10052.314% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -686533.166% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -375569.464% |
| MaxCyte, Inc. | 17.96 Million USD | -7504.207% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -2471501.187% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | -1367.559% |
| PAVmed Inc | 2.96 Million USD | -46062.162% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -21889.057% |
| RxSight, Inc. | 1.21 Million USD | -112732.37% |
| Sight Sciences, Inc. | 31.7 Million USD | -4209.323% |
| SI-BONE, Inc. | 36.06 Million USD | -3688.715% |
| TELA Bio, Inc. | 40.51 Million USD | -3272.578% |
| Treace Medical Concepts, Inc. | 53 Million USD | -2477.724% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -89735.634% |
| Acutus Medical, Inc. | 32.65 Million USD | -4084.48% |
| Talis Biomedical Corporation | 16.78 Million USD | -8040.117% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -33679.975% |
| CVRx, Inc. | 30.38 Million USD | -4397.4% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -134265.197% |
| Bioventus Inc. | 366.99 Million USD | -272.318% |
| Venus Concept Inc. | 70.79 Million USD | -1830.216% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -109739.228% |
| LivaNova PLC | 568.54 Million USD | -140.334% |
| 908 Devices Inc. | 3.92 Million USD | -34677.297% |
| Alphatec Holdings, Inc. | 511.03 Million USD | -167.379% |
| Nemaura Medical Inc. | 3.08 Million USD | -44153.706% |
| NeuroPace, Inc. | 56.95 Million USD | -2299.129% |
| LENSAR, Inc. | 1.75 Million USD | -77980.0% |
| Apyx Medical Corporation | 33.18 Million USD | -4017.523% |
| Cutera, Inc. | 418.69 Million USD | -226.347% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -8982.691% |
| BioSig Technologies, Inc. | 103 Thousand USD | -1326501.942% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -4978.799% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -13634.044% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 7.988% |
| Axonics, Inc. | 25.84 Million USD | -5187.926% |
| Outset Medical, Inc. | 134.59 Million USD | -915.194% |
| IRIDEX Corporation | 1.75 Million USD | -77935.408% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | -2561.524% |
| IRadimed Corporation | 1.61 Million USD | -84502.62% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -776263.636% |
| INVO Bioscience, Inc. | 6.77 Million USD | -20065.03% |
| Telesis Bio, Inc. | 5.26 Million USD | -25832.815% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -22782.824% |
| Varex Imaging Corporation | 464.2 Million USD | -194.356% |
| Quipt Home Medical Corp. | 60.82 Million USD | -2146.589% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -232280.952% |
| Pulmonx Corporation | 35.08 Million USD | -3794.098% |
| Dynatronics Corporation | 3.25 Million USD | -41833.688% |
| Modular Medical, Inc. | 817 Thousand USD | -167146.022% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -904800.662% |
| Semler Scientific, Inc. | 70 Thousand USD | -1951900.0% |
| InMode Ltd. | 6.61 Million USD | -20562.332% |
| Bruker Corporation | 1.14 Billion USD | -19.388% |
| Cytosorbents Corporation | 2.54 Million USD | -53634.834% |
| DexCom, Inc. | 2.57 Billion USD | 46.893% |
| Align Technology, Inc. | 96.96 Million USD | -1309.125% |
| Viveve Medical, Inc. | 5.12 Million USD | -26566.667% |
| ZimVie Inc. | 508.79 Million USD | -168.555% |
| Movano Inc. | 15.00 USD | -9109333233.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -7438.759% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | -242.794% |
| Profound Medical Corp. | 4.97 Million USD | -27368.54% |
| enVVeno Medical Corporation | 1.06 Million USD | -128321.053% |
| Surmodics, Inc. | 29.4 Million USD | -4546.829% |
| iCAD, Inc. | 273 Thousand USD | -500412.821% |
| Nuwellis, Inc. | 221 Thousand USD | -618180.543% |
| Biotricity, Inc. | 10.85 Million USD | -12486.782% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -3809.585% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -210195.944% |
| InspireMD, Inc. | 1.03 Million USD | -131537.765% |
| PAVmed Inc. | 2.96 Million USD | -46062.162% |
| BIOLASE, Inc. | 13.98 Million USD | -9670.468% |
| Beyond Air, Inc. | 14.72 Million USD | -9181.978% |
| FONAR Corporation | 37.92 Million USD | -3502.482% |
| AxoGen, Inc. | 46.6 Million USD | -2832.0% |
| Vivani Medical, Inc. | 19.31 Million USD | -6975.027% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | -2962.853% |
| Inari Medical, Inc. | 30.35 Million USD | -4401.4% |
| UFP Technologies, Inc. | 28 Million USD | -4780.0% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -314706.068% |
| Tenon Medical, Inc. | 428 Thousand USD | -319152.336% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -136267.265% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -63389.113% |
| AdaptHealth Corp. | 2.09 Billion USD | 34.766% |
| Sintx Technologies, Inc. | 3.68 Million USD | -36959.94% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | -3570.849% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -232280.952% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -229161.745% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | -53.142% |
| TransMedics Group, Inc. | 506.2 Million USD | -169.931% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -225007.084% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -1477328.772% |
| Hyperfine, Inc. | 64 Thousand USD | -2134900.0% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | -623.963% |
| Biomerica, Inc. | 459 Thousand USD | -297590.632% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -303893.699% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -719107.104% |
| Silk Road Medical, Inc | 75.62 Million USD | -1706.786% |